Cisplatin is a cornerstone chemotherapeutic for ovarian cancer, yet its clinical utility is constrained by severe systemic toxicity and acquired drug resistance. Here we report a novel platinum (IV) prodrug, US-CIS-OH, generated by conjugating cisplatin with ursolic acid (UA), a natural pentacyclic triterpenoid with...
Zi-Qi Pan, Zhi-Ying Qin, Zi-Yu Qian et al.· Journal of Medicinal Chemist...· 0 citations
Protein posttranslational modifications (PTMs) build up the diversity and complexity of the proteome, and their dysregulation is intrinsically linked to various diseases. The study of PTMs has profoundly broadened the scope of therapeutic target discovery. Building upon the success of PROTACs, this heterobifunctional p...
Chen Zhang, Hui Ye, Yi-Hua Zhang et al.· Chemistry· 0 citations
This review systematically assesses the progress, core strengths, and key translational barriers of four mainstream anti-echinococcosis drug development avenues over the past five years to provide a crucial theoretical foundation and practical reference for precise disease control, optimized clinical strategies, and th...
Lin Wang, Zhengsheng Yan, Si Chen et al.· Current Medicinal Chemistry· 0 citations
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.